2019 Speakers

Edward Kim, M.D.

Levine Cancer Institute

Geoffrey Kim, M.D.

AstraZeneca

Bellinda King-Kallimanis, Ph.D.

U.S. Food and Drug Administration

Paul Kluetz, M.D.

U.S. Food and Drug Administration

Virginia Kwitkowski, M.S., ANCP-BC

U.S. Food and Drug Administration

Denis Lacombe, M.D.

European Organisation for Research and Treatment of Cancer

Allison Leahy

Children’s Hospital of Philadelphia

Nicole LeBoeuf, M.D., M.P.H.

Dana-Farber Cancer Institute

Chi-Chung Li

Genentech Roche

Meijuan Li, Ph.D.

U.S. Food an Drug Administration

Steven H. Lin, M.D., Ph.D.

MD Anderson Cancer Center

Ke Liu, M.D., Ph.D.

U.S. Food an Drug Administration

Nicolas Llosa, M.D.

Johns Hopkins University

Pat LoRusso, D.O.

Yale University

H. Kim Lyerly, M.D.

Duke University, AAADV Chair

Francois Maigne

National Institute for Health and Care Excellence, UK

Jennifer Malin, M.D., Ph.D.

UnitedHealthCare

Kenneth Mandl, M.D., M.P.H.

Boston Children’s Hospital

Leigh Marcus, M.D.

U.S. Food and Drug Administration

Jaigi Mathai, Ph.D.

Health Canada

Sharon McBain, B.Sc.

Global Regulatory Leader

Johnson & Johnson

Robert McCormack, Ph.D.

Independent Consultant

Salina Miller

FDA

Candis Morrison, Ph.D., CRNP

U.S. Food and Drug Admnistration

Aaron Moss, Ph.D.

Certara

Jan Mueller-Berghaus

Head of unit

Paul-Ehrlich-Institut

Sumimasa Nagai

Pharmaceuticals and Medical Devices Agency, Japan

Abhilasha Nair

Medical Officer

US Food and Drug Administration

Nisha Nanda, B.Sc., Ph.D.

Loxo Oncology

Gwen Nichols, M.D.

Leukemia and Lymphoma Society

Kim Norris

Lung Cancer Foundation Of America

Kelly Norsworthy

U.S. Food and Drug Administration

Justin Odegaard, M.D., Ph.D.

Guardant Health

Ho Jung Oh, Ph.D.

Ministry of Food and Drug Safety (MFDS), Korea

Olanrewaju Okusanya, Pharm.D., M.S.

U.S. Food and Drug Administration

Funmi Olopade, M.D.

University of Chicago

Christy Osgood, M.D.

U.S. Food and Drug Administration

Geoffrey R. Oxnard, M.D.

Dana-Farber Cancer Insititute, Harvard University

Richard Pazdur, M.D.

U.S. Food and Drug Administration

Michael Pearl, M.D.

Stony Brook Medicine

Jian Peng, M.D., Ph.D.

Shenogen

Jane Perlmutter, Ph.D., M.B.A., Patient Advocate

Gemini Group, Patient Advocate

Reena Philip, Ph.D.

U.S. Food and Drug Administration

Elisabeth Piault-Louis

Genentech

Anuradha Poonepalli

Health Sciences Authority

Laurel Pracht

Gynecologic Oncology Group / NRG Oncology Cooperative Group

Tatiana Prowell

U.S. Food and Drug Administration

Alexander Putman, Ph.D.

U.S. Food and Drug Administration

David Raben, M.D.

University of Colorado Denver

Wayne Rackoff, M.D.

Janssen Research Development

Kate Rawson

Prevision Policy/The Pink Sheet

Gregory Reaman, M.D.

U.S. Food and Drug Administration

S. Eswara Reddy, Ph.D.

Central Drugs Standard Control Organization, India

Jun Ren

Capital Medical University Cancer Center, Beijing, China/Duke University Medical Center

Isaac Rodriguez-Chavez, Ph.D., M.H.Sc., M.Sc.

U.S. Food and Drug Administration

Donna Roscoe, Ph.D.

U.S. Food and Drug Administration

Eric Rubin, M.D.

Merck Research Labaoratories

Hope Rugo, M.D.

University of California San Francisco

Leonard Sacks, M.D.

U.S. Food and Drug Administration

Abby Sandler

National Cancer Institute

Aaron Schetter

U.S. Food and Drug Administration

Richard Schilsky, M.D.

American Society of Clinical Oncology

Lowell Schnipper, M.D.

Harvard University, Beth Israel Deaconess Medical Center

Mary Scroggins, M.A.

International Gynecologic Cancer Society, PInkie Hugs LLC

Chris Scull

Biologics Consulting

Kelly Shanahan, M.D.

Patient Advocate

Elad Sharon

National Cancer Institute

Qian Shi

Mayo Clinic

Diane Simeone, M.D.

New York University Langone Health

Richard Simon, D.Sc.

R Simon Consulting

Harpreet Singh, M.D.

U.S. Food and Drug Administration

Romi Singh, Ph.D.

Pfizer

Arun Singhal

Government of India

Jean Charles Soria

AstraZeneca

Patty Spears

UNC Lineberger Comprehensive Cancer Center

Alex Spira

Asst professor of oncology

Johns Hopkins

Rajeshwari Sridhara, Ph.D.

U.S. Food and Drug Administration

Martin Stockler, MBBS

University Of Sydney

Johee Sul, M.D.

U.S. Food and Drug Administration

Katherine Szarama

CMS

Lisa Taylor

Patient Advocate, NRG Oncology

Margaret Tempero, M.D.

University of California San Francisco

Pamela Tenaerts

Clinical Trials Transformation Initiative

Craig Tendler, M.D.

Janssen

Marc Theoret, M.D.

U.S. Food and Drug Admnistration

Ching Tian

Novartis

Steve Usdin

BioCentury

Jonathon Vallejo, Ph.D.

U.S. Food and Drug Administration

Janaki Veeraraghavan, Ph.D.

U.S. Food and Drug Administration

Christine Vietz

Foundation Medicine

Nikhil Wagle, M.D.

Dana-Farber Cancer Institute

Desiree Walker

Patient Advocate, Young Survival Coalition

Kelly Walkovich, M.D.

University of Michigan

Blake Warner

NIDCR

Jeffrey Weber, M.D., Ph.D.

New York University Langone Health

Matthew Wiener, Pharm.D.

Pharmatech, Inc.

P. Mickey Williams, Ph.D.

Frederick National Laboratories for Cancer Research

Xiaolei Xu

Agilent

Reiko Yanagihara

Pharmaceuticals and Medical Devices Agency, Japan

Jingjing Ye

FDA

Yousuf Zafar, M.D.

Duke University

Ahmet Zehir, Ph.D.

Memorial Sloane Kettering Cancer Center

Dan Zhang, M.D., Ph.D.

Fountain Medical Development Ltd.

Hong Zhang

reviewer

CDE

Ming Zhou

CDE